weight [orga]    
Relate [orch]    
Effect [qlco]    
Disease Progression [patf]    
Hepatitis C [dsyn]    
Antiviral [phsu]    
long-term treatment [hlca]    
Cirrhosis [dsyn]    
Trial [resa]    
Background [cnce]    
Aim [idcn]    
limit [ftcn]    
Efficacy [qlco]    
Current Therapy [topp]    
Hepatitis C, Chronic [dsyn]    
Risk factor [qnco]    
Liver disease [dsyn]    
progress [patf]    
Obese [dsyn]    
Associated [qlco]    
Liver disease [dsyn]    
examinations [fndg]    
Effect [qlco]    
weight [orga]    
Relate [orch]    
condition [dsyn]    
Disease Outcome [fndg]    
Hepatitis C [dsyn]    
Antiviral [phsu]    
long-term treatment [hlca]    
Cirrhosis [dsyn]    
Trial [resa]    
Method [inpr]    
patient [podg]    
Evaluable [ftcn]    
progress [patf]    
Liver disease [dsyn]    
Not [ftcn]    
Relate [orch]    
Hepatocellular carcinoma [neop]    
Clinical [qlco]    
Outcome [ftcn]    
3 5 [qnco]    
year [tmco]    
patient [podg]    
progress [patf]    
Cirrhosis [dsyn]    
Protocol [inpr]    
biopsied [diap]    
patient [podg]    
Bridging fibrosis [patf]    
Cohort [popg]    
Entry [inpr]    
Result [ftcn]    
studies [mnob]    
Entry [inpr]    
median [spco]    
Body Mass Index [diap]    
High [qlco]    
kg-m [qnco]    
weight [orga]    
Relate [orch]    
condition [dsyn]    
include [ftcn]    
Diabetes [dsyn]    
High [qlco]    
median [spco]    
Waist Circumference [clna]    
Insulin Resistance [patf]    
Update [tmco]    
Homeostasis model assessment [lbpr]    
Insulin Resistance [patf]    
IR [geoa]    
Non-invasive [ftcn]    
Measurable [qnco]    
IR [geoa]    
Most [qnco]    
Associated [qlco]    
Outcome [ftcn]    
Hazard Ratio [qnco]    
1+ [qnco]    
Quartile [qlco]    
Increase [ftcn]    
1+ [qnco]    
Presence [topp]    
Steatosis [patf]    
baseline [bodm]    
biopsied [diap]    
Associated [qlco]    
Increase [qnco]    
Outcome [ftcn]    
Rate [acty]    
patient [podg]    
Bridging fibrosis [patf]    
Decrease [qnco]    
Rate [acty]    
patient [podg]    
Cirrhosis [dsyn]    
Presence [topp]    
Mallory Bodies [fndg]    
Associated [qlco]    
Outcome [ftcn]    
Hazard Ratio [qnco]    
1+ [qnco]    
1/2 [inpr]    
31 [inpr]    
Significance [qnco]    
Weight change [fndg]    
>5 [qnco]    
First [qnco]    
year [tmco]    
RANDOM [resa]    
Hazard Ratio [qnco]    
1+ [qnco]    
Categories [inpr]    
Increase [ftcn]    
weight [orga]    
Cl - [elii]    
1+ [qnco]    
55 [inpr]    
Conclusion [idcn]    
Insulin Resistance [patf]    
Histologic [ftcn]    
Feature [qlco]    
Liver disease [dsyn]    
Weight change [fndg]    
Associated [qlco]    
Outcome [ftcn]    
Hepatitis C, Chronic [dsyn]    
Improved [cnce]    
weight [orga]    
Relate [orch]    
Factor [ftcn]    
Modified [ftcn]    
Disease Progression [patf]    
